Mesa Laboratories Inc (MLAB) stock
MLABNasdaqIndustrial Instruments For Measurement, Display, and ControlFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3091% above fair value
$137.81+3.21 (+2.38%)
Close on Nov 18, 2026Market cap $771.17MP/E 162.1Yield 0.46%
Mesa Laboratories free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Mesa Laboratories's free cash flow for the twelve months ending Jun 30, 2026 was $52.87M, up 57.4% year over year. For fiscal 2026 it was $39.58M, down 7.0% from the year before. The highest annual figure on record is $42.56M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $39.58M | -7.0% |
| FY2025 | Mar 31, 2025 | $42.56M | +2.4% |
| FY2024 | Mar 31, 2024 | $41.57M | +77.3% |
| FY2023 | Mar 31, 2023 | $23.44M | -32.6% |
| FY2022 | Mar 31, 2022 | $34.79M | -0.8% |
| FY2021 | Mar 31, 2021 | $35.08M | +37.6% |
| FY2020 | Mar 31, 2020 | $25.49M | -13.0% |
| FY2019 | Mar 31, 2019 | $29.29M | +27.8% |
| FY2018 | Mar 31, 2018 | $22.92M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $14.18M | +1503.7% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $13.55M | +13.7% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $18.02M | +4.1% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $7.13M | +104.7% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $884.00K | -91.0% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $11.91M | -3.6% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $17.32M | +66.4% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $3.48M | -61.9% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $9.85M | +1.9% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $12.35M | +7.4% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $10.41M | +71.6% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $9.14M | +2.5% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $9.67M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $11.49M | +34.9% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $6.06M | -56.2% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $8.92M | +155.1% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$3.04M | -134.0% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $8.52M | -31.7% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $13.84M | +29.4% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $3.50M | -64.5% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $8.94M | +337.2% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $12.48M | +50.9% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $10.70M | +0.8% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $9.86M | +61.4% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $2.04M | +310.4% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $8.27M | -19.0% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $10.62M | +9.1% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $6.11M | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $498.00K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $10.21M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $9.73M | – |
See a number that looks wrong?